Jiaojian Lv

机构：Lishui University, Lishui Central Hospital, Lishui City People's Hospital, 58.com (China)

发表论文 37 篇 · 总被引 239 次 · h-index 8

代表论文

• Noninvasive Quantification of Hepatic Steatosis Using Ultrasound‐Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study (2025 · MedComm · 被引 17)
• Xiaoyao San's dual efficacy in NAFLD and depression: Unraveling the mechanisms via network pharmacology and multi-omics (2025 · Phytomedicine · 被引 9)
• Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306) (2024 · Clinical and Molecular Hepatology · 被引 9)
• Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China (2024 · BMJ Open · 被引 7)
• Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study (2023 · Hepatology International · 被引 5)
• Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop‐CN model (NCRCID‐CHESS 2106): a prospective multicenter study (2024 · MedComm · 被引 4)